Melqart Asset Management’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-4,700,000
| Closed | -$3.24M | – | 178 |
|
|
2020
Q4 | $3.24M | Buy |
4,700,000
+3,150,900
| +203% | +$2.17M | 0.24% | 73 |
|
|
2020
Q3 | $3.49M | Sell |
1,549,100
-300,900
| -16% | -$677K | 0.39% | 51 |
|
|
2020
Q2 | $6.62M | Sell |
1,850,000
-475,000
| -20% | -$1.7M | 0.82% | 22 |
|
|
2020
Q1 | $8.84M | Buy |
2,325,000
+525,900
| +29% | +$2M | 0.87% | 23 |
|
|
2019
Q4 | $5.42M | Buy |
+1,799,100
| New | +$5.42M | 0.45% | 31 |
|